Delivery Order SPE2DB20D2104-SPE2DB23FS77W
Award Date 3/27/23
Potential Completion Date 3/28/23
Potential Value $1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Albuterol HFA 90 MCG inhalers. The contract has a firm-fixed-price of $1,997.88 and a period of performance through November 16, 2023. The award is not designated under any set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,609.68 firm-fixed-price contract is for the delivery of 4,567,104,771 units of the albuterol HFA 90 mcg inhaler with an ultimate completion date of January 31, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,105.80, is for the delivery of Albuterol HFA 90 MCG inhalers with an ultimate completion date of February 10, 2025. The contract is a firm-fixed-price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is also the holder of a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Albuterol HFA 90 MCG inhalers, with a total ceiling value of $8,079.24 and a performance period through March 5, 2025. The contract is a firm fixed-price, delivery order type, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Albuterol HFA 90 MCG inhalers. The contract has a ceiling value of $1,980.76 and a period of performance through March 12, 2025. It is a firm-fixed price contract without any set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Albuterol HFA 90 MCG Inhaler 8.5GM. The fixed-price contract has a ceiling value of $1,951.08 and an ultimate completion date of November 15, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
- This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of albuterol HFA 90 mcg inhalers. The contract is a firm fixed-price Delivery Order with a ceiling value of $2,590.75 and an ultimate completion date of September 19, 2024. The contract has no set-aside designation. As a significant federal contractor, Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Albuterol HFA 90 MCG Inhaler 8.5GM. The contract has a ceiling value of $1,440.00 and a completion date of June 24, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor for this award and holds a larger Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of albuterol HFA 90 mcg inhalers. The $1,019.00 firm fixed-price contract has a completion date of July 2, 2024. The award is not associated with a set-aside program. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at $999,999,999 and...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,073.76, is for the supply of Albuterol HFA 90 MCG inhalers to support military healthcare programs. The contract is a firm fixed-price, delivery order contract with a completion date of May 5, 2023. The contract is not designated as a set-aside procurement. AmerisourceBergen holds a...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FS77WDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Albuterol HFA 90 MCG Inhaler 18GM. The order is a firm fixed-price contract with a ceiling value of $1,029.35 and a completion date of March 28, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is not designated as a set-aside contract.
Generated 2/27/25, 12:18 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 3/27/23 |